Pzena Investment Management LLC Invests $231,000 in Humana Inc. (NYSE:HUM)

Pzena Investment Management LLC acquired a new position in shares of Humana Inc. (NYSE:HUM) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 476 shares of the insurance provider’s stock, valued at approximately $231,000.

A number of other large investors also recently modified their holdings of HUM. Cibc World Market Inc. boosted its stake in shares of Humana by 4.0% during the 1st quarter. Cibc World Market Inc. now owns 5,709 shares of the insurance provider’s stock worth $2,484,000 after buying an additional 217 shares during the last quarter. Blair William & Co. IL boosted its stake in shares of Humana by 0.6% during the 1st quarter. Blair William & Co. IL now owns 5,660 shares of the insurance provider’s stock worth $2,463,000 after buying an additional 32 shares during the last quarter. Cetera Investment Advisers boosted its stake in shares of Humana by 0.5% during the 1st quarter. Cetera Investment Advisers now owns 4,906 shares of the insurance provider’s stock worth $2,135,000 after buying an additional 26 shares during the last quarter. Sequoia Financial Advisors LLC boosted its stake in shares of Humana by 19.0% during the 1st quarter. Sequoia Financial Advisors LLC now owns 615 shares of the insurance provider’s stock worth $268,000 after buying an additional 98 shares during the last quarter. Finally, Candriam Luxembourg S.C.A. raised its holdings in shares of Humana by 25.0% in the 1st quarter. Candriam Luxembourg S.C.A. now owns 29,809 shares of the insurance provider’s stock valued at $12,971,000 after purchasing an additional 5,964 shares during the period. 91.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on HUM shares. Morgan Stanley dropped their target price on shares of Humana from $637.00 to $624.00 and set an “overweight” rating on the stock in a report on Wednesday, August 30th. Barclays dropped their target price on shares of Humana from $620.00 to $585.00 in a report on Monday, June 19th. Truist Financial upped their target price on shares of Humana from $530.00 to $550.00 and gave the company a “hold” rating in a report on Thursday, August 3rd. TD Cowen dropped their target price on shares of Humana from $616.00 to $613.00 and set an “outperform” rating on the stock in a report on Tuesday, August 15th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on shares of Humana from $468.00 to $628.00 and gave the company a “buy” rating in a report on Monday, August 7th. Four research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $592.30.

Humana Stock Down 0.9 %

NYSE HUM opened at $467.73 on Friday. The company has a current ratio of 1.37, a quick ratio of 1.37 and a debt-to-equity ratio of 0.58. Humana Inc. has a 1-year low of $423.29 and a 1-year high of $571.30. The company has a 50 day moving average of $465.41 and a 200-day moving average of $488.01. The company has a market cap of $57.96 billion, a price-to-earnings ratio of 17.45, a PEG ratio of 1.22 and a beta of 0.66.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $8.94 earnings per share for the quarter, beating analysts’ consensus estimates of $8.88 by $0.06. Humana had a net margin of 3.42% and a return on equity of 20.70%. The company had revenue of $26.75 billion during the quarter, compared to the consensus estimate of $25.83 billion. During the same period in the previous year, the business earned $8.67 earnings per share. The firm’s quarterly revenue was up 13.0% on a year-over-year basis. On average, equities research analysts expect that Humana Inc. will post 28.25 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 29th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $3.54 dividend on an annualized basis and a yield of 0.76%. Humana’s dividend payout ratio (DPR) is 13.21%.

About Humana

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.